arrow
S

Sara Ramella

azienda ospedaliero universitaria careggi
H指数:29
被引数:4,585

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Broad baseline-variable profiling of visceral conversion in bone-only HR+/ HER2-metastatic breast cancer treated with CDK4/6 inhibitors

骨转移性HR+/HER2-转移性乳腺癌经CDK4/6抑制剂治疗后腹腔转化的大范围基线-变量分析

2026-09-011
OA
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone Metastases

CDK4/6抑制剂在HR+/HER2-骨转移性乳腺癌患者中的真实世界无进展生存比较

2026-05-010
OA
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)

关于肺癌合并间质性肺病患者放射治疗推荐:意大利放射治疗与临床肿瘤学会(AIRO)的Delphi共识过程

2025-11-030
PRE
Total HIP arthroplasty following pelvic irradiation: a systematic review focusing on the last two decades (vol 35, 409, 2025)

骨盆照射后的全髋关节置换术:一项关注过去二十年的系统综述(卷 35,409,2025)

2025-10-140
OAAI
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study

乳腺癌:曲妥珠单抗-德鲁克特肯与放射治疗:COMBART前瞻性队列研究的 safety 子分析

2025-09-010
OAAI
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort
2024-10-012
PRE
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies
2024-10-011
OAAI
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)
2024-07-312
OAAI
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
2024-06-012
OAAI